Dynamic Liver Graft Preservation in Controlled Donation After Circulatory Death: What Is the Best Fit?
Xavier Muller, Guillaume Rossignol, Kayvan Mohkam, Mickaël Lesurtel, Jean‐Yves Mabrut – 9 October 2021
DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis
Hong‐Zhong Zhou, Fan Li, Sheng‐Tao Cheng, Yong Xu, Hai‐Jun Deng, Da‐Yong Gu, Jin Wang, Wei‐Xian Chen, Yu‐Jiao Zhou, Min‐Li Yang, Ji‐Hua Ren, Lu Zheng, Ai‐Long Huang, Juan Chen – 8 October 2021
Letter to the editor: Short‐term data on machine perfusion should be extrapolated with caution
Dev Katarey – 8 October 2021
Bmal1 regulates production of larger lipoproteins by modulating cAMP‐responsive element‐binding protein H and apolipoprotein AIV
Xiaoyue Pan, M. Mahmood Hussain – 8 October 2021
The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach
Tommy Ivanics, Walter Nelson, Madhukar S. Patel, Marco P.A.W. Claasen, Lawrence Lau, Andre Gorgen, Phillipe Abreu, Anna Goldenberg, Lauren Erdman, Gonzalo Sapisochin – 8 October 2021 – Liver transplantation (LT) listing criteria for hepatocellular carcinoma (HCC) remain controversial. To optimize the utility of limited donor organs, this study aims to leverage machine learning to develop an accurate posttransplantation HCC recurrence prediction calculator. Patients with HCC listed for LT from 2000 to 2016 were identified, with 739 patients who underwent LT used for modeling.
Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study
Lanlan Chen, Hongqun Yang, Haitao Li, Chang He, Liu Yang, Guoyue Lv – 7 October 2021
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay
Vinay Sundaram, Rajiv Jalan – 7 October 2021
Macrophage nuclear factor erythroid 2‐related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3–mediated RhoA/ROCK pathway in the ischemic liver
Jianhua Rao, Jiannan Qiu, Ming Ni, Hao Wang, Peng Wang, Lei Zhang, Zeng Wang, Mu Liu, Feng Cheng, Xuehao Wang, Ling Lu – 7 October 2021
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand
Jess Howell, Avik Majumdar, Michael A. Fink, Mandy Byrne, Geoff McCaughan, Simone I. Strasser, Michael Crawford, Peter Hodgkinson, Katherine A. Stuart, Caroline Tallis, John Chen, Alan Wigg, Robert Jones, Bryon Jaques, Gary Jeffrey, Leon Adams, Michael C. Wallace, Stephen Munn, Ed Gane, Alex J.
A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients
Jieling Xiao, Jie Ning Yong, Cheng Han Ng, Nicholas Syn, Wen Hui Lim, Darren Jun Hao Tan, En Ying Tan, Daniel Huang, Raymond C. Wong, Nicholas W. S. Chew, Eunice Xiang Xuan Tan, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah – 7 October 2021 – The shift in the changing etiology of cirrhosis requiring liver transplantation (LT) has resulted in an increasing prevalence of coronary artery disease (CAD) that can potentially impact post‐LT outcomes.